Inhibition of RXR and PPARγ ameliorates diet-induced obesity and type 2 diabetes

PPARγ is a ligand-activated transcription factor and functions as a heterodimer with a retinoid X receptor (RXR). Supraphysiological activation of PPARγ by thiazolidinediones can reduce insulin resistance and hyperglycemia in type 2 diabetes, but these drugs can also cause weight gain. Quite unexpec...

詳細記述

書誌詳細

出版年:	J Clin Invest
主要な著者:	Yamauchi, Toshimasa, Waki, Hironori, Kamon, Junji, Murakami, Koji, Motojima, Kiyoto, Komeda, Kajuro, Miki, Hiroshi, Kubota, Naoto, Terauchi, Yasuo, Tsuchida, Atsuko, Tsuboyama-Kasaoka, Nobuyo, Yamauchi, Naoko, Ide, Tomohiro, Hori, Wataru, Kato, Shigeaki, Fukayama, Masashi, Akanuma, Yasuo, Ezaki, Osamu, Itai, Akiko, Nagai, Ryozo, Kimura, Satoshi, Tobe, Kazuyuki, Kagechika, Hiroyuki, Shudo, Koichi, Kadowaki, Takashi
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Clinical Investigation 2001
主題:	Article
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC200951/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11581301/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI12864
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!